Caxton Associates LLP Liquidia Corp Transaction History
Caxton Associates LLP
- $4.11 Billion
- Q3 2025
A detailed history of Caxton Associates LLP transactions in Liquidia Corp stock. As of the latest transaction made, Caxton Associates LLP holds 17,121 shares of LQDA stock, worth $489,318. This represents 0.01% of its overall portfolio holdings.
Number of Shares
17,121Holding current value
$489,318% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding LQDA
# of Institutions
237Shares Held
54MCall Options Held
6.33MPut Options Held
7.87M-
Farallon Capital Management LLC San Francisco, CA8.57MShares$245 Million0.85% of portfolio
-
Black Rock Inc. New York, NY4.24MShares$121 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.96MShares$113 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY2.83MShares$80.9 Million25.4% of portfolio
-
Goldman Sachs Group Inc New York, NY2.78MShares$79.5 Million0.01% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.84B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...